Select language:

Sputnik V to be produced in Iran, Serbia and Italy

 / Главная / Russkiy Mir Foundation / News / Sputnik V to be produced in Iran, Serbia and Italy

Sputnik V to be produced in Iran, Serbia and Italy


14.04.2021

Photo credit: jarmoluk / pixabay.com

The production of the Russian Sputnik V vaccine will soon begin at Serbian and Iranian factories, TASS reports. According to the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev, in a few months, the drug will be launched in Italy.

The head of the RDIF added that the vaccine is produced in Belarus and Kazakhstan. He assured that RDIF is entering into partnerships with many countries and with a variety of companies.

It is planned to reach full production capacity of Sputnik V abroad in April. RDIF has entered into agreements with 20 manufacturers from 10 countries. Еhe production of Sputnik V in Russia is now carried out at 7n sites: in the Gamalei Center, Binnopharme, Biocade, Generium, R-Pharm, Lecco and Pharmstandard.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.